Medtronic (MDT) Cash from Investing Activities Growth (1y) (2015 - 2026)
Medtronic (MDT) Cash from Investing Activities Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -208.79% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -397.90% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -514.25% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -187.82% |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | -211.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | -87.14% |
| Jan 23, 2026 | 3.20% |
| Oct 24, 2025 | -39.71% |
| Jul 25, 2025 | -177.61% |
| Apr 25, 2025 | 29.60% |
| Jan 24, 2025 | -19.24% |
| Oct 25, 2024 | 18.63% |
| Jul 26, 2024 | 51.95% |
| Apr 26, 2024 | -46.53% |
| Jan 26, 2024 | -146.34% |
| Oct 27, 2023 | 63.00% |
| Jul 28, 2023 | 65.99% |
| Apr 28, 2023 | -275.28% |
| Jan 27, 2023 | 34.32% |
| Oct 28, 2022 | -61.64% |
| Jul 29, 2022 | -102.17% |
| Apr 29, 2022 | -85.88% |
| Jan 28, 2022 | 84.24% |
| Oct 29, 2021 | 64.90% |
| Jul 30, 2021 | -9,900.00% |